Bausch + Lomb lands Class I recall status after broken syringes harm patients

Medical device maker Bausch + Lomb gets the FDA's highest-risk recall label over syringe components that have, in rare instances, broken during injection and left patients with serious injuries.

Eye care giant Bausch + Lomb received the FDA's highest-risk classification for a recall of several lots of sterile cannulas after a few patients were seriously injured with the small tubes detached from syringes during injection.

The FDA gave the recall Class I status, generally reserved for recalls which "involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death," according to the FDA notice.